The Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) was established to address anticipated needs for post-marketed evidence generation for novel biologics, their corresponding biosimilars and other related products.
AMCP webinar that addresses the science behind data consortiums, and also looks at why AMCP is engaging data consortiums, managed care specialty drug experts, researchers and industry to help launch the AMCP Biosimilars Collective Intelligence Consortium before the first biosimilars hit the market.
